Anne O'Donnell Luria, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rare Diseases | 12 | 2024 | 630 | 3.300 |
Why?
|
| Genetic Variation | 18 | 2024 | 6612 | 1.370 |
Why?
|
| Genome, Human | 15 | 2024 | 4443 | 0.810 |
Why?
|
| Genomics | 11 | 2023 | 5923 | 0.770 |
Why?
|
| Inheritance Patterns | 1 | 2023 | 345 | 0.740 |
Why?
|
| Phenotype | 31 | 2024 | 16724 | 0.720 |
Why?
|
| Genetic Testing | 9 | 2024 | 3591 | 0.680 |
Why?
|
| Heterozygote | 6 | 2024 | 2795 | 0.540 |
Why?
|
| DNA Copy Number Variations | 3 | 2024 | 2045 | 0.540 |
Why?
|
| Genetic Association Studies | 9 | 2022 | 2746 | 0.520 |
Why?
|
| Hyperammonemia | 1 | 2017 | 80 | 0.520 |
Why?
|
| Glutamine | 1 | 2017 | 575 | 0.450 |
Why?
|
| Software | 6 | 2024 | 4466 | 0.430 |
Why?
|
| Coma | 1 | 2017 | 485 | 0.420 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 329 | 0.420 |
Why?
|
| Genetic Predisposition to Disease | 16 | 2024 | 18075 | 0.400 |
Why?
|
| Databases, Genetic | 8 | 2023 | 1756 | 0.400 |
Why?
|
| DNA Methylation | 7 | 2024 | 4427 | 0.390 |
Why?
|
| Genome | 7 | 2023 | 1752 | 0.390 |
Why?
|
| Computational Biology | 5 | 2024 | 3564 | 0.380 |
Why?
|
| Haploinsufficiency | 4 | 2023 | 334 | 0.380 |
Why?
|
| Sequence Analysis, DNA | 8 | 2024 | 4780 | 0.370 |
Why?
|
| Penetrance | 4 | 2023 | 388 | 0.370 |
Why?
|
| Arthrogryposis | 2 | 2022 | 69 | 0.350 |
Why?
|
| Muscular Diseases | 3 | 2024 | 551 | 0.350 |
Why?
|
| Muscular Dystrophies | 2 | 2023 | 393 | 0.330 |
Why?
|
| Gene Frequency | 8 | 2024 | 3624 | 0.320 |
Why?
|
| Mutation | 21 | 2024 | 30213 | 0.310 |
Why?
|
| Cytosine | 1 | 2009 | 212 | 0.300 |
Why?
|
| Microcephaly | 2 | 2023 | 427 | 0.290 |
Why?
|
| Epilepsy | 2 | 2021 | 3317 | 0.280 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3681 | 0.270 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2024 | 606 | 0.270 |
Why?
|
| Genetics, Population | 2 | 2023 | 943 | 0.270 |
Why?
|
| DNA-Binding Proteins | 3 | 2024 | 9611 | 0.270 |
Why?
|
| Humans | 89 | 2024 | 766766 | 0.260 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2021 | 1657 | 0.250 |
Why?
|
| Isotopes | 1 | 2004 | 125 | 0.240 |
Why?
|
| alpha-Glucosidases | 1 | 2004 | 46 | 0.240 |
Why?
|
| Disease | 2 | 2020 | 675 | 0.240 |
Why?
|
| Consanguinity | 2 | 2017 | 460 | 0.230 |
Why?
|
| Craniofacial Abnormalities | 2 | 2024 | 320 | 0.230 |
Why?
|
| RNA, Small Nuclear | 1 | 2024 | 71 | 0.230 |
Why?
|
| De Lange Syndrome | 1 | 2024 | 22 | 0.220 |
Why?
|
| Mammals | 1 | 2009 | 1133 | 0.220 |
Why?
|
| Turner Syndrome | 1 | 2015 | 129 | 0.220 |
Why?
|
| Solvents | 1 | 2004 | 299 | 0.220 |
Why?
|
| Mutation, Missense | 5 | 2024 | 2590 | 0.220 |
Why?
|
| Developmental Disabilities | 4 | 2023 | 1519 | 0.220 |
Why?
|
| Genetic Counseling | 2 | 2021 | 634 | 0.220 |
Why?
|
| Pedigree | 6 | 2021 | 4539 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2024 | 534 | 0.200 |
Why?
|
| Exons | 3 | 2023 | 2392 | 0.200 |
Why?
|
| Nanopores | 1 | 2022 | 45 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 3666 | 0.190 |
Why?
|
| Vestibular Diseases | 1 | 2024 | 232 | 0.190 |
Why?
|
| Zebrafish | 2 | 2024 | 3035 | 0.190 |
Why?
|
| Intranuclear Space | 1 | 2021 | 15 | 0.190 |
Why?
|
| Neuromuscular Diseases | 1 | 2024 | 260 | 0.190 |
Why?
|
| Homozygote | 4 | 2021 | 1775 | 0.180 |
Why?
|
| Face | 2 | 2024 | 1029 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2020 | 2978 | 0.180 |
Why?
|
| Primates | 1 | 2023 | 519 | 0.180 |
Why?
|
| Hematologic Diseases | 1 | 2024 | 502 | 0.170 |
Why?
|
| Brain | 10 | 2024 | 27159 | 0.170 |
Why?
|
| Selection, Genetic | 3 | 2023 | 878 | 0.170 |
Why?
|
| Calibration | 1 | 2022 | 814 | 0.170 |
Why?
|
| Chloride Channels | 1 | 2021 | 221 | 0.170 |
Why?
|
| Ophthalmoplegia | 1 | 2021 | 168 | 0.170 |
Why?
|
| Uniparental Disomy | 1 | 2019 | 46 | 0.170 |
Why?
|
| Abnormalities, Multiple | 2 | 2024 | 1424 | 0.170 |
Why?
|
| CpG Islands | 4 | 2020 | 1208 | 0.160 |
Why?
|
| Chromosome Deletion | 1 | 2024 | 1384 | 0.160 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 332 | 0.160 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2022 | 271 | 0.160 |
Why?
|
| Child | 18 | 2024 | 80668 | 0.160 |
Why?
|
| Chromosome Mapping | 4 | 2023 | 4619 | 0.160 |
Why?
|
| Adenosine Deaminase | 1 | 2021 | 253 | 0.160 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 174 | 0.160 |
Why?
|
| Movement Disorders | 1 | 2023 | 461 | 0.160 |
Why?
|
| Genes, Essential | 1 | 2020 | 185 | 0.160 |
Why?
|
| Infertility, Female | 1 | 2015 | 763 | 0.160 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 255 | 0.160 |
Why?
|
| Hydroxocobalamin | 1 | 2018 | 27 | 0.160 |
Why?
|
| Anemia, Megaloblastic | 1 | 2018 | 24 | 0.160 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 300 | 0.150 |
Why?
|
| Cohort Studies | 9 | 2024 | 41710 | 0.150 |
Why?
|
| Uncertainty | 1 | 2023 | 764 | 0.150 |
Why?
|
| Membrane Glycoproteins | 2 | 2020 | 3702 | 0.150 |
Why?
|
| Eczema | 1 | 2020 | 244 | 0.150 |
Why?
|
| Physicians | 1 | 2016 | 4591 | 0.150 |
Why?
|
| Child, Preschool | 13 | 2024 | 42577 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 536 | 0.150 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 526 | 0.140 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 1425 | 0.140 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2018 | 147 | 0.140 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2021 | 336 | 0.140 |
Why?
|
| Sodium Benzoate | 1 | 2017 | 14 | 0.140 |
Why?
|
| Genetics, Medical | 1 | 2020 | 334 | 0.140 |
Why?
|
| Tubulin | 1 | 2021 | 694 | 0.140 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2017 | 57 | 0.140 |
Why?
|
| Xenopus Proteins | 1 | 2020 | 434 | 0.140 |
Why?
|
| Marfan Syndrome | 1 | 2019 | 237 | 0.140 |
Why?
|
| Neuropeptides | 1 | 2023 | 950 | 0.140 |
Why?
|
| Phenylacetates | 1 | 2017 | 112 | 0.140 |
Why?
|
| Male | 35 | 2024 | 364142 | 0.140 |
Why?
|
| Cerebral Palsy | 1 | 2022 | 481 | 0.140 |
Why?
|
| Genome-Wide Association Study | 6 | 2024 | 12806 | 0.140 |
Why?
|
| Nephrotic Syndrome | 1 | 2021 | 381 | 0.140 |
Why?
|
| DNA Mutational Analysis | 4 | 2020 | 4114 | 0.140 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2018 | 125 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2024 | 698 | 0.130 |
Why?
|
| Embryo, Nonmammalian | 1 | 2020 | 910 | 0.130 |
Why?
|
| Female | 33 | 2024 | 396520 | 0.130 |
Why?
|
| Multigene Family | 1 | 2019 | 1081 | 0.130 |
Why?
|
| Ion Channels | 1 | 2021 | 1043 | 0.130 |
Why?
|
| Carrier Proteins | 2 | 2021 | 4924 | 0.130 |
Why?
|
| Adolescent | 14 | 2024 | 88904 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 712 | 0.130 |
Why?
|
| Gene Deletion | 3 | 2019 | 2669 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2023 | 3450 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2020 | 634 | 0.130 |
Why?
|
| Glutamates | 1 | 2017 | 384 | 0.130 |
Why?
|
| Body Patterning | 1 | 2020 | 634 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 2093 | 0.120 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 735 | 0.120 |
Why?
|
| Alleles | 6 | 2024 | 6895 | 0.120 |
Why?
|
| Facies | 3 | 2021 | 224 | 0.120 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 844 | 0.120 |
Why?
|
| Prion Diseases | 1 | 2016 | 99 | 0.120 |
Why?
|
| Genotype | 7 | 2023 | 13036 | 0.110 |
Why?
|
| Dyslipidemias | 1 | 2021 | 872 | 0.110 |
Why?
|
| Autistic Disorder | 1 | 2023 | 1238 | 0.110 |
Why?
|
| Fibrosis | 1 | 2021 | 2077 | 0.110 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 2059 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2060 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 1172 | 0.110 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 4712 | 0.110 |
Why?
|
| Genes | 1 | 2017 | 1824 | 0.110 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 832 | 0.100 |
Why?
|
| Histones | 2 | 2022 | 2593 | 0.100 |
Why?
|
| Health | 1 | 2016 | 397 | 0.100 |
Why?
|
| Infant | 8 | 2024 | 36461 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2017 | 415 | 0.100 |
Why?
|
| Syndrome | 3 | 2024 | 3271 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 4400 | 0.100 |
Why?
|
| Failure to Thrive | 2 | 2024 | 139 | 0.090 |
Why?
|
| Young Adult | 6 | 2024 | 59939 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2011 | 203 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2902 | 0.090 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 1742 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2014 | 626 | 0.090 |
Why?
|
| RNA Splice Sites | 2 | 2024 | 212 | 0.090 |
Why?
|
| Base Sequence | 3 | 2023 | 12415 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2024 | 16044 | 0.080 |
Why?
|
| Internet | 1 | 2022 | 3113 | 0.080 |
Why?
|
| Psychiatry | 1 | 2022 | 1715 | 0.080 |
Why?
|
| Virulence | 2 | 2024 | 1294 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1885 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2017 | 820 | 0.080 |
Why?
|
| Adult | 12 | 2024 | 223307 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2023 | 4276 | 0.080 |
Why?
|
| Access to Information | 2 | 2023 | 317 | 0.080 |
Why?
|
| Muscle, Skeletal | 4 | 2024 | 4970 | 0.070 |
Why?
|
| Open Reading Frames | 2 | 2022 | 818 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2014 | 1127 | 0.070 |
Why?
|
| Animals | 16 | 2024 | 168930 | 0.070 |
Why?
|
| Methyltransferases | 1 | 2009 | 373 | 0.070 |
Why?
|
| Patient Selection | 1 | 2018 | 4252 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7609 | 0.070 |
Why?
|
| Pakistan | 2 | 2017 | 300 | 0.060 |
Why?
|
| Nucleosomes | 1 | 2009 | 492 | 0.060 |
Why?
|
| Evolution, Molecular | 2 | 2011 | 1892 | 0.060 |
Why?
|
| Proteins | 1 | 2020 | 6002 | 0.060 |
Why?
|
| Methylglucosides | 1 | 2004 | 35 | 0.060 |
Why?
|
| Deuterium Oxide | 1 | 2004 | 34 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 141 | 0.060 |
Why?
|
| Chromatin | 2 | 2022 | 2977 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13411 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11920 | 0.060 |
Why?
|
| Enzyme Stability | 1 | 2004 | 218 | 0.060 |
Why?
|
| Hypertrichosis | 1 | 2024 | 31 | 0.060 |
Why?
|
| Spliceosomes | 1 | 2024 | 116 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 2039 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2004 | 645 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2024 | 142 | 0.050 |
Why?
|
| National Human Genome Research Institute (U.S.) | 1 | 2023 | 22 | 0.050 |
Why?
|
| Suicide | 1 | 2014 | 1606 | 0.050 |
Why?
|
| Dystroglycans | 1 | 2023 | 62 | 0.050 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2023 | 60 | 0.050 |
Why?
|
| Actinin | 1 | 2024 | 165 | 0.050 |
Why?
|
| Karyotyping | 1 | 2015 | 1176 | 0.050 |
Why?
|
| Cell Line | 3 | 2021 | 15563 | 0.050 |
Why?
|
| Informatics | 1 | 2023 | 72 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2023 | 12150 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2022 | 6869 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2022 | 12791 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18330 | 0.050 |
Why?
|
| Blepharophimosis | 1 | 2021 | 21 | 0.050 |
Why?
|
| Dystrophin | 1 | 2023 | 283 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 355 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2021 | 40 | 0.050 |
Why?
|
| Mice | 8 | 2023 | 81889 | 0.050 |
Why?
|
| S Phase | 1 | 2002 | 424 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2024 | 625 | 0.050 |
Why?
|
| Glucosyltransferases | 1 | 2021 | 94 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13640 | 0.050 |
Why?
|
| Scrotum | 1 | 2021 | 117 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2021 | 159 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2021 | 149 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1750 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2020 | 43 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2885 | 0.040 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2015 | 503 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 2002 | 476 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2478 | 0.040 |
Why?
|
| Myoblasts | 1 | 2021 | 234 | 0.040 |
Why?
|
| User-Computer Interface | 2 | 2019 | 1409 | 0.040 |
Why?
|
| Patella | 1 | 2021 | 317 | 0.040 |
Why?
|
| Genetic Loci | 2 | 2021 | 2630 | 0.040 |
Why?
|
| Middle Aged | 9 | 2024 | 223257 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 287 | 0.040 |
Why?
|
| Protons | 1 | 2004 | 1097 | 0.040 |
Why?
|
| Siblings | 1 | 2023 | 828 | 0.040 |
Why?
|
| Glycine | 1 | 2022 | 670 | 0.040 |
Why?
|
| Autopsy | 1 | 2023 | 1011 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 917 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2020 | 507 | 0.040 |
Why?
|
| Psychopathology | 1 | 2022 | 434 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2021 | 253 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 932 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 723 | 0.040 |
Why?
|
| Aging | 2 | 2014 | 8731 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 792 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 498 | 0.040 |
Why?
|
| Filipin | 1 | 2017 | 14 | 0.040 |
Why?
|
| Temperature | 1 | 2004 | 2233 | 0.040 |
Why?
|
| Australia | 1 | 2021 | 1263 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2023 | 1103 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 326 | 0.040 |
Why?
|
| Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
| Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2018 | 239 | 0.040 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2018 | 119 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 113 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12245 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6287 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 551 | 0.030 |
Why?
|
| Binding Sites | 2 | 2021 | 6012 | 0.030 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
| Podocytes | 1 | 2021 | 404 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1010 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 434 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 369 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2021 | 751 | 0.030 |
Why?
|
| Muscles | 1 | 2021 | 1576 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 645 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2020 | 965 | 0.030 |
Why?
|
| Liver Failure, Acute | 1 | 2017 | 182 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2019 | 573 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2002 | 1155 | 0.030 |
Why?
|
| Kidney | 2 | 2021 | 7074 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 1271 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 224 | 0.030 |
Why?
|
| Apolipoprotein C-III | 1 | 2017 | 209 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9525 | 0.030 |
Why?
|
| Ribosomes | 1 | 2018 | 496 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 3439 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1772 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 792 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2021 | 3073 | 0.030 |
Why?
|
| Educational Status | 1 | 2022 | 2510 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2017 | 320 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6507 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2019 | 1211 | 0.030 |
Why?
|
| Haplotypes | 1 | 2021 | 2727 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1838 | 0.030 |
Why?
|
| Prions | 1 | 2016 | 177 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3721 | 0.030 |
Why?
|
| Joint Instability | 1 | 2021 | 803 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 702 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14471 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2678 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2060 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65273 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 367 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1186 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 844 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 3609 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 803 | 0.030 |
Why?
|
| Glucose | 1 | 2004 | 4340 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3208 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 3601 | 0.020 |
Why?
|
| Prevalence | 2 | 2019 | 15835 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20144 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2021 | 1725 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2021 | 1704 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1308 | 0.020 |
Why?
|
| Fathers | 1 | 2014 | 377 | 0.020 |
Why?
|
| Fertility | 1 | 2016 | 770 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 30237 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2021 | 5386 | 0.020 |
Why?
|
| Fasting | 1 | 2017 | 1609 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2018 | 1142 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 162 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 6066 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 26389 | 0.020 |
Why?
|
| Triglycerides | 1 | 2017 | 2441 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2001 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2354 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 14072 | 0.020 |
Why?
|
| Seizures | 1 | 2021 | 2996 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 24295 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7208 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
| Mental Health | 1 | 2022 | 3270 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2007 | 224 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 1663 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1894 | 0.020 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 3824 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 959 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5368 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2208 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17088 | 0.010 |
Why?
|
| Cognition | 1 | 2022 | 7057 | 0.010 |
Why?
|
| Motor Activity | 1 | 2014 | 2711 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7868 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2007 | 1159 | 0.010 |
Why?
|
| United States | 2 | 2023 | 72951 | 0.010 |
Why?
|
| Risk Factors | 2 | 2023 | 74881 | 0.010 |
Why?
|
| Species Specificity | 1 | 2007 | 2413 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2017 | 5915 | 0.010 |
Why?
|
| G2 Phase | 1 | 2002 | 134 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7571 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7585 | 0.010 |
Why?
|
| Breast | 1 | 2010 | 1971 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 171343 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15908 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3757 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1243 | 0.010 |
Why?
|
| Genes, BRCA1 | 1 | 2002 | 753 | 0.010 |
Why?
|
| Serine | 1 | 2002 | 828 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22248 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23619 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29948 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18397 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11513 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6104 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 5754 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 81635 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15657 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36567 | 0.010 |
Why?
|
| DNA Damage | 1 | 2002 | 2467 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 2801 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 59550 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 8307 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 21162 | 0.000 |
Why?
|